Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein

Atherosclerosis

Volumn 135, Issue 2, 1997, Pages 193-204

  Graham, Annette ^a   Hassall, David G ^b   Rafique, Samina ^a   Owen, James S ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antioxidant; Atherosclerosis; High density lipoprotein subclasses; Paraoxonase; Phospholipids

Indexed keywords

ARYLESTERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN PURIFICATION;

APOLIPOPROTEINS; ARYLDIALKYLPHOSPHATASE; ESTERASES; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION; TUMOR CELLS, CULTURED;

EID: 0031470431     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00162-7     Document Type: Article

References (61)

1. Mackness M.I., Abbot C., Arrol S., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129.
2. Mackness M.I., Arrol S., Durrrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286:1991;152.
3. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 96:1995;2882.
4. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J., Shih D.M., Van Lenten B.J., Frank J.S., Demer L.L., Edwards P.A., Fogelman A.M. The yin and yang of oxidation in the development of the fatty streak. Arterio Thromb Vasc Biol. 16:1996;831.
5. Tribble D.L., Chu B.M., Gong E.L., van Venrooij F., Nichols A.V. HDL antioxidant effects as assessed using a nonexchangeable probe to monitor particle-specific peroxidative stress in LDL-HDL mixtures. J Lipid Res. 36:1995;2580.
6. Miller N.E. Association of high-density lipoprotein subclasses and apolipoproteins with ischaemic heart disease and coronary atherosclerosis. Am Heart J. 113:1987;589.
7. Johansson J., Carlson L.A., Landon C., Hamsten A. High density lipoproteins and coronary atherosclerosis. Atheroscler Thromb. 11:1991;174.
8. Gerrity R.G. The role of the monocyte in atherogenesis. Am J Pathol. 103:1981;181.
9. Parthasarathy S., Barnett J., Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1044:1990;275.
10. Mackness M.I., Arrol S., Abbott C., Durrington P.N. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J. 294:1993;829.
11. 2+ catalyzed oxidation of human low density lipoprotein. FEBS Lett. 257:1989;435.
12. Kunitake S.T., Jarvis M.R., Hamilton R.L., Kane J.P. Binding of transition metals by apolipoprotein AI containing plasma lipoproteins: inhibition of oxidation of low-density lipoproteins. Proc Natl Acad Sci USA. 89:1992;6993.
13. Navab M., Imes S.S., Hama S.Y., Hough G.P., Ross L.A., Bork R.W., Valente A.J., Berliner J.A., Drinkwater D.C., Laks H., Fogelman A.M. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 88:1991;2039.
14. Klimov A.N., Gurevich V.S., Nikiforova A.A., Shatilina L.V., Kuzmin A.A., Plavinsky S.L., Teryukova N.P. Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis. 100:1993;13.
15. Watson A.D., Navab M., Hama S.Y., Sevanian A., Prescott S.M., Stafforini D.M., McIntyre T.M., La Du B.N., Fogelman A.M., Berliner J.A. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest. 95:1995;774.
16. Liu M., Subbaiah P.V. Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase. Proc Natl Acad Sci USA. 91:1994;6035.
17. Van Lenten B.J., Hama S.Y., de Beer F.C., Stafforini D.M., McIntyre T.M., Prescott S.M., La Du B.N., Fogelman A.M., Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 96:1995;2758.
18. Shih D.M., Gu L., Hama S., Xia Y.R., Navab M., Fogelman A.M., Lusis A.J. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest. 97:1996;1630.
19. Szedlacsek S.E., Wasowicz E., Hulea S.A., Nishida H.I., Kummerow F.A., Nishida T. Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J Biol Chem. 270:1995;11812.
20. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., Hegele R.A. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 7:1996;69.
21. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulphur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem. 262:1987;10098.
22. Sparrow C.P., Olszewski J. Cellular oxidation of low-density lipoprotein is caused by thiol production in media containing transition metals. J Lipid Res. 34:1993;1219.
23. Graham A., Wood J.L., O'Leary V.J., Stone D. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism. Free Rad Res. 21:1994;295.
24. Wood J.L., Graham A. Structural requirements for oxidation of low-density lipoprotein by thiols. FEBS Lett. 366:1995;75.
25. Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 286:1992;901.
26. Santanam N., Parthasarathy S. Cellular cysteine generation does not contribute to the initiation of LDL oxidation. J Lipid Res. 36:1995;2203.
27. Cheung B.W., Wilkinson T., Geer J.C., Segrest J.P. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 21:1980;284.
28. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 3:1990;77.
29. Desai K., Bruckdorfer K.R., Hutton R.A., Owen J.S. Binding of apoE-rich high-density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J Lipid Res. 30:1989;831.
30. Owen J.S., Gillett M.P.T., Hughes T.E. Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei. J Lipid Res. 33:1992;1639.
31. Osborne J.C. Delipidation of plasma lipoproteins. Methods Enzymol. 128:1986;213.
32. James R.W., Hochstrasser D., Tissot J.D., Funk M., Appel R., Barja F., Pellegrini C., Muller A.F., Pometta D. Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res. 29:1988;1557.
33. Blatter Garin M.-C., Abbott C., Messmer S., Mackness M.I., Durrington P.N., Pometta D., James R.W. Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J. 304:1994;549.
34. Lamb D.J., Leake D.S. The effect of EDTA on the oxidation of low density lipoprotein. Atherosclerosis. 94:1992;35.
35. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids. 26:1991;853.
36. Jiang Z.Y., Hunt J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low-density lipoprotein. Anal Biochem. 202:1992;384.
37. Steinbrecher U.P., Zhang H., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Rad Biol Med. 9:1990;155.
38. Givan A.L., Proud G., Taylor R.M.R. A rapid, objective method for the detection of lymphocytotoxic antibodies using flow cytometry. J Immunol Methods. 99:1987;137.
39. McGinnes K., Chapman G., Marks R., Penny R. A fluorescence NK assay using flow cytometry. J Immunol Methods. 86:1986;7.
40. Frei B., Gaziano J.M. Content of antioxidant, preformed lipid hydroperoxides and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res. 34:1993;2135.
41. Hessler J.R., Robertson A.L., Chisolm G.M. LDL induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 32:1979;213.
42. Henriksen T., Evensen S.A., Carlander B. Injury to cultured endothelial cells induced by low-density lipoproteins: protection by high density lipoproteins. Scand J Clin Lab Invest. 39:1979;369.
43. Main A.R. The differentiation of the A-type esterases in sheep serum. Biochem J. 75:1960;188.
44. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nature Genet. 14:1996;55.
45. Eisenberg S.J. High density lipoprotein metabolism. J Lipid Res. 25:1984;1017.
46. 3 to inhibition of LDL oxidation by human macrophages. Biochem Soc Trans. 24:1996;396S.
47. Warden C.H., Hedrick C.C., Qiao J.-H., Castellani L.W., Lusis A.J. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261:1993;469.
48. Miyazaki A., Sakai M., Suginohara Y., Hakamata H., Sakamoto Y.-I., Morikawa W., Horicuhi S. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem. 269:1994;5264.
49. Albers J.J., Tu A.-Y., Wolfbauer G., Cheung M.C., Marcovina S.M. Molecular biology of phospholipid transfer protein. Curr Opin Lipidol. 7:1996;88.
50. Kostner G., Oettl K., Jauhiainen M., Ehnholm C., Esterbauer H., Dieplinger H. Human plasma phospholipid transfer protein accelerates exchange/transfer of α-tocopherol between lipoproteins and cells. Biochem J. 305:1995;659.
51. Thomas M.J., Thornburg T., Manning J., Hooper K., Rudel L.L. Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry. 33:1994;1828.
52. Zoeller R.A., Morand O.H., Raetz C.R.H. A possible role for plasmalogens in protecting animals cells against photosensitized killing. J Biol Chem. 263:1988;11590.
53. Esterbauer H. The chemistry of oxidation of lipoproteins. In: Rice-Evans C, Bruckdorfer KR, editors. Oxidative Stress, Lipoproteins and Cardiovascular Dysfunction. London: Portland Press, 1995.
54. Engelmann B., Brautigam C., Thiery J. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochem Biophys Res Commun. 204:1994;1235.
55. Cheung M.C., Wolf A.C., Lum K.D., Tollefson J.H., Albers J.J. Distribution and localization of lecithin:cholesterol acyltransferase and cholesterol ester transfer activity in AI containing lipoproteins. J Lipid Res. 27:1986;1135.
56. Kelso G.J., Stuart W.D., Richter R.J., Furlong C.E., Jordan-Starck T.C., Harmony J.A.K. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry. 33:1994;832.
57. Harmony J.A.K. Apolipoprotein J: a membrane policeman? Curr Opin Lipidol. 3:1992;75.
58. 2 on the oxidative modification of lipoproteins. J Vasc Res. 33(1):1996;62.
59. Dentan C., Lesnik P., Chapman M.J., Ninio E. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation. Arterio Thromb. 14(3):1994;353.
60. Ambrosio G., Oriente A., Napoli C., Palumbo G., Chiariello P., Marone G., Condorelli M., Chiariello M., Triggiani M. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J Clin Invest. 93:1994;2408.
61. Chen C., Loo G. Effect of peroxyl radicals on lecithin:cholesterol acyltransferase activity in human plasma. Lipids. 30:1995;627.